Merck KGaA (OTCMKTS:MKGAF – Get Free Report)’s stock price was down 5.3% on Monday . The company traded as low as $155.0850 and last traded at $155.0850. Approximately 178 shares changed hands during mid-day trading, a decline of 73% from the average daily volume of 650 shares. The stock had previously closed at $163.7780.
Merck KGaA Price Performance
The firm’s 50 day moving average is $139.86 and its 200-day moving average is $142.02. The firm has a market cap of $20.18 billion, a PE ratio of 23.84 and a beta of 0.96. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Further Reading
- Five stocks we like better than Merck KGaA
- Short Sellers Are Piling Into Wingstop, But Analysts See Big Upside
- Synchrony’s Comeback Is Hiding in Plain Sight
- Uranium Energy Corp Melts Down—Nuclear Opportunity at Hand
- Optical Cable Corporation: Strong Earnings, But Hurdles Remain
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
